Skip to content

Endovascular treatment of aortic arch chronic dissection with a branched endograft following previous ascending aorta replacement for Acute Type A dissection: midterm results from an international multicenter study

Endovascular treatment of aortic arch chronic dissection with a branched endograft following previous ascending aorta replacement for Acute Type A dissection: midterm results from an international multicenter study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN16716994
Enrollment
70
Registered
2018-06-11
Start date
2017-12-02
Completion date
Unknown
Last updated
2019-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic arch chronic dissection following ascending aorta prosthetic replacement for acute Stanford A dissection Circulatory System

Interventions

Endovascular repair of aortic arch chronic dissection with a custom made branched endograft (Cook Medical, Bloomington, In, USA). Endografts includes 2 branched (one for the brachiocep

Sponsors

Centre Chirurgical Marie Lannelongue
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 or older 2. With prior ascending aorta prosthetic replacement for Stanford A acute dissection 3. With chronic dissection of the aortic arch with arch dilatation 4. Treated with a custom-made branched endograft (Cook Medical, Bloomington, In, USA)

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

MeasureTime frame
Rates of in-hospital mortality and stroke, measured during the postoperative course (between surgical procedure and postoperative day 30)

Secondary

MeasureTime frame
1. Technical success, defined as successful delivery of the endograft without type 1 endoleak and evaluated on the preoperative angiogram, without death during the first 24 postoperative hours. Measured during the beginning of the surgical procedure and postoperative hour 24 2. Early complications, measured using evaluation of the presence of cardiac (troponin elevation with electrocardiogram modification), renal (elevation of creatinin level requiring extracorporeal epuration) or respiratory (hypoxemia, pneumoniae or reintubation) failure or necessity of secondary surgical procedure. Measured before postoperative day 30 3. Late complications, measured using the same measurement as early complications 4. Re-intervention and mortality rates measured during follow up (between postoperative day 30 and the most recent news)

Countries

Brazil, France, Germany, Hong Kong, Netherlands, Poland, Sweden, United Kingdom, United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026